LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
We have reported that human immunodeficiency virus type 1 (HIV-1) integrase (IN) forms a specific nuclear complex with human lens epithelium-derived growth factor/transcription co-activator p75 (LEDGF/p75) protein. We now studied the IN-LEDGF/p75 interaction and nuclear import of IN in living cells using fusions of IN and LEDGF/p75 with enhanced green fluorescent protein and far-red fluorescent protein HcRed1. We show that both the N-terminal zinc binding domain and the central core domains of IN are involved in the interaction with LEDGF/p75. Both domains are essential for nuclear localization of IN as well as for the association of IN with condensed chromosomes during mitosis. However, upon overexpression of LEDGF/p75, the core domain fragment of IN was recruited to the nuclei and mitotic chromosomes with a distribution pattern characteristic of the full-length protein, indicating that it harbors the main determinant for interaction with LEDGF/p75. Although the C-terminal domain of IN was dispensable for nuclear/chromosomal localization, a fusion of the C-terminal IN fragment with enhanced green fluorescent protein was found exclusively in the nucleus, with a diffuse nuclear/nucleolar distribution, suggesting that the C-terminal domain may also play a role in the nuclear import of IN. In contrast to LEDGF/p75, its alternative splice variant, p52, did not interact with HIV-1 IN in vitro and in living cells. Finally, RNA interference-mediated knock-down of endogenous LEDGF/p75 expression abolished nuclear/chromosomal localization of IN. We conclude, therefore, that the interaction with LEDGF/p75 accounts for the karyophilic properties and chromosomal targeting of HIV-1 IN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The CCD is the main IN binding determinant, with the NTD contributing secondary interactions for full binding affinity106,107.”
From Structure and function of retroviral integrase (2022) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Digital Image Processing: PIKS Inside
Pratt, W. K. (2002) · Wiley eBooks · doi:10.1002/0471221325 · Cited by 4,340
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C., & Popovic, M. (1986) · Science · doi:10.1126/science.3014648 · Cited by 1,807
Digital image processing (2nd ed.)
(1992) · CVGIP: Image Understanding · doi:10.1016/1049-9660(92)90019-y · Cited by 1,780
Nucleocytoplasmic transport: the soluble phase
Mattaj, I. W., & Englmeier, L. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.265 · Cited by 1,175
Analysis of gene function in somatic mammalian cells using small interfering RNAs
Elbashir, S. (2002) · Methods · doi:10.1016/s1046-2023(02)00023-3 · Cited by 1,095
Caplen, N. J., Parrish, S., Imani, F., Fire, A., & Morgan, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171251798 · Cited by 1,043
Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., & Naldini, L. (2000) · Nature Genetics · doi:10.1038/76095 · Cited by 927
Integration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Research works printed but not linked: 2
- Cherepanov, 2000, FASEB J., 14, 1389
- Emiliani, 2003, 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 10–14, 2003, Abstr. 74lb
Cited by
Items 301–400 of 499
Proteomics in the investigation of HIV‐1 interactions with host proteins
Li, M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400101 · Cited by 16
“Numerous later studies have shown that LEDGF/p75 is essential for strand transfer activity of viral IN [66, 67].”
BackgroundBurlein, C., Wang, C., Xu, M., Bhatt, T., Stahlhut, M. W., Ou, Y., Adam, G. C., Heath, J., Klein, D. J., Sanders, J. M., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00550 · Cited by 14
Inhibitors of the integrase–transportin-SR2 interaction block HIV nuclear import
Demeulemeester, J., Blokken, J., Houwer, S. D., Dirix, L., Klaassen, H., Marchand, A., Chaltin, P., Christ, F., & Debyser, Z. (2018) · Retrovirology · doi:10.1186/s12977-018-0389-2 · Cited by 15
Self-citationNaidu, B. N., Patel, M., McAuliffe, B. V., Ding, B., Cianci, C., Simmermacher, J., Jenkins, S., Parker, D. D., Sivaprakasam, P., Khan, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02169 · Cited by 14
Regulation of Foamy Viral Transcription and RNA Export
Bodem, J. (2011) · Advances in virus research · doi:10.1016/b978-0-12-385885-6.00006-7 · Cited by 17
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage Leukemia
Čermáková, K., Weydert, C., Christ, F., Rijck, J. D., & Debyser, Z. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.005 · Cited by 14
Self-citationZhang, X., Huang, S., Gu, W.-G., Yang, L., Chen, H., Zheng, C., Zhao, Y., Wan, D. C., & Zheng, Y. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60031-5 · Cited by 16
Chen, M., Yan, C., Zheng, L., & Zhang, X. (2021) · Chemical Science · doi:10.1039/d1sc04839b · Cited by 13
Singh, P., Li, W., Bedwell, G., Fadel, H., Poeschla, E., & Engelman, A. (2022) · Viruses · doi:10.3390/v14091883 · Cited by 13
The Interaction of HIV-1 with the Host Factors
Komano, J. A., Futahashi, Y., Urano, E., Miyauchi, K., Murakami, T., Matsuda, Z., & Yamamoto, N. (2005) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2005.125 · Cited by 13
Tilton, C. A., Tabler, C. O., Lucera, M. B., Marek, S. L., Haqqani, A. A., & Tilton, J. C. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.08.029 · Cited by 14
“Host proteins modulating infection efficiency include cofactors used by the virus to promote replication, such as LEDGF/p75 (Maertens et al., 2003), and antiviral restriction factors such as SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundA Symmetric Region of the HIV-1 Integrase Dimerization Interface Is Essential for Viral Replication
Serrao, E., Thys, W., Demeulemeester, J., Al‐Mawsawi, L. Q., Christ, F., Debyser, Z., & Neamati, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045177 · Cited by 16
“Genbank) accession numbers for the proteins discussed in this paper are LEDGF/p75 (NM_033222) and HIV-1 NL4-3 IN (U26942).”
BackgroundInfluentialSelf-citationHost Cell Factors and HIV-1 Integration
Engelman, A. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.415 · Cited by 14
“Reducing LEDGF/p75 levels through targeted RNA interference (RNAi) had dramatic consequences on expression: the majority of HIV-1 IN relocalized to the cell cytoplasm [43,44], which was accompanied by significant reductions in its steady-state levels [43,45].”
BackgroundInfluentialInteractions of Host Proteins with the Murine Leukemia Virus Integrase
Studamire, B., & Goff, S. P. (2010) · Viruses · doi:10.3390/v2051110 · Cited by 14
“targeting of HIV-1 integrase [78] and what appears to be an essential role in HIV-1 integration and”
Bennett, G. R., Peters, R., Wang, X., Hanne, J., Sobol, R. W., Bundschuh, R. A., Fishel, R. A., & Yoder, K. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103164 · Cited by 14
“chromatin via a PWWP domain and two AT hook motifs [8–16].”
Hecke, C. V., Trypsteen, W., Malatinková, E., Spiegelaere, W. D., Vervisch, K., Rutsaert, S., Loes, S. K., Sips, M., & Vandekerckhove, L. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.006 · Cited by 16
“PSIP1 encodes an integrase dependency factor (LEDGF/p75) [45,46] and is not linked to VL or IFN response.”
Virus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
Self-citationYun, H. S., Baek, J., Yim, J.-H., Lee, S., Lee, C., Song, J., Um, H., Park, J. K., Park, I., & Hwang, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.039 · Cited by 12
“LEDGF has been shown to function as a transcriptional activator and to potentiate the activity of human immunodeficiency virus integrase [5].”
BackgroundRashamuse, T. J., Fish, M. Q., Coyanis, E. M., & Bode, M. L. (2021) · Molecules · doi:10.3390/molecules26206203 · Cited by 13
Lopez, A. P., Kugelman, J. R., Garcia-Rivera, J. A., Urias, E., Salinas, S. A., Fernández-Zapico, M. E., & Llano, M. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.013 · Cited by 14
N-terminal half of transportin SR2 interacts with HIV integrase
Tsirkone, V. G., Blokken, J., Wit, F. D., Breemans, J., Houwer, S. D., Debyser, Z., Christ, F., & Strelkov, S. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777029 · Cited by 16
“Cloning, expression, and purification of tagged protein constructs for AlphaScreen assay was done essentially as described previously (8, 62).”
MethodSelf-citationTargeting Cellular Cofactors in HIV Therapy
Dürr, R., Keppler, O. T., Christ, F., Crespan, E., Garbelli, A., Maga, G., & Dietrich, U. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_45 · Cited by 12
Bradley, C. M., & Craigie, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509078102 · Cited by 14
Cavalluzzo, C., Christ, F., Voet, A. R. D., Sharma, A. K., Singh, B. K., Zhang, K. Y. J., Lescrinier, E., Maeyer, M. D., Debyser, Z., & der Eycken, E. V. V. (2013) · Journal of Peptide Science · doi:10.1002/psc.2543 · Cited by 11
Self-citationCharacterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression
Messiaen, P., Spiegelaere, W. D., Alcamí, J., Vervisch, K., Acker, P. V., Verhasselt, B., Meuwissen, P., Calonge, E., Gonzàlez, N., Gutiérrez, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050204 · Cited by 11
Belle, S. V., Ashkar, S. E., Čermáková, K., Matthijssens, F., Goossens, S., Canella, A., Hodges, H. C., Christ, F., Rijck, J. D., Vlierberghe, P. V., et al. (2021) · Cells · doi:10.3390/cells10010192 · Cited by 12
“Flag-tagged LEDGF/p75 purification was performed as described before [43].”
MethodSelf-citationVoet, A. R. D., Maeyer, M. D., Debyser, Z., & Christ, F. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.86 · Cited by 11
Self-citationWang, H., Shun, M.-C., Li, X., Nunzio, F. D., Hare, S., Cherepanov, P., & Engelman, A. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2013.2 · Cited by 12
Self-citationVercammen, J., Maertens, G. N., & Engelborghs, Y. (2007) · Springer series on fluorescence · doi:10.1007/4243_2007_009 · Cited by 12
Self-citationBurdick, R. C., Deléage, C., Duchon, A. A., Estes, J. D., Hu, W.-S., & Pathak, V. K. (2022) · mBio · doi:10.1128/mbio.03256-21 · Cited by 13
Development of an RNAi-Based Gene Therapy against HIV-1
ter Brake, O., & Berkhout, B. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00296 · Cited by 11
HIV Virions as Nanoscopic Test Tubes for Probing Oligomerization of the Integrase Enzyme
Borrenberghs, D., Thys, W., Rocha, S., Demeulemeester, J., Weydert, C., Dedecker, P., Hofkens, J., Debyser, Z., & Hendrix, J. (2014) · ACS Nano · doi:10.1021/nn406615v · Cited by 13
“Wild-type IN-His6 and the point mutant INW108G-His6 were purified as described previously.(26) The assay buffer was 25 mM Tris/HCl pH 7.”
MethodSelf-citationGonçalves, J., Moreira, E., Sequeira, I. J., Rodrigues, A. S., Rueff, J., & Brás, A. (2016) · International Journal of Genomics · doi:10.1155/2016/2168590 · Cited by 15
“The interaction with LEDGF/p75 accounts for the karyophilic properties and chromosomal targeting of HIV-1 IN [46].”
Development of an RNAi based gene therapy against HIV-1
ter Brake, O. (2007) · UvA-DARE (University of Amsterdam) · Cited by 11
HIV-1 Integrase Inhibition: Looking at Cofactor Interactions
Christ, F., & Debyser, Z. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.162 · Cited by 10
Self-citationMolecular Mechanism of LEDGF/p75 Dimerization
Lux, V., Brouns, T., Čermáková, K., Srb, P., Fábry, M., Mádlíková, M., Hořejší, M., Kukačka, Z., Novák, P., Kugler, M., et al. (2020) · Structure · doi:10.1016/j.str.2020.08.012 · Cited by 10
Self-citationEmbryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice
Wang, H., Shun, M.-C., Dickson, A. K., & Engelman, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137797 · Cited by 12
Targeting Protein–Protein Interactions for HIV Therapeutics
Rice, A. P., & Sutton, R. E. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.369 · Cited by 11
“com domain (IBD) [96–100], and reduction in LEDGF protein levels in cells in culture altered the integration-site choice of HIV-1 [101].”
BackgroundInayoshi, Y., Okino, Y., Miyake, K., Mizutani, A., Yamamoto-Kishikawa, J., Kinoshita, Y., Morimoto, Y., Imamura, K., Morshed, M., Kono, K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02681-09 · Cited by 14
“Among these factors, a physical interaction has been reported between HIV-1 IN and INI1 (24, 69), EED (56), and LEDGF/p75 (3, 5, 34), as well as between avian sarcoma virus (ASV) IN and Daxx (18).”
BackgroundProtein-Protein Interactions as Drug Targets
Wendt, M. D. (2012) · Topics in Medicinal Chemistry · doi:10.1007/978-3-642-28965-1_1 · Cited by 9
Dai, Y., Li, E., Chen, D., Niu, X., Wang, Z., Lu, L., & Zheng, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.913714 · Cited by 9
“The DFS70/ LEDGFp75 is a prosurvival factor that confers resistance to apoptosis induced by cell stress (1) and is also involved as a cofactor in HIV replication through an interaction with viral integrase (3).”
BackgroundRole of LEDGF/p75 (PSIP1) in oncogenesis. Insights in molecular mechanism and therapeutic potential
Akele, M. Z., Iervolino, M., Belle, S. V., Christ, F., & Debyser, Z. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189248 · Cited by 8
Self-citationLuca, L. D., Agharbaoui, F. E., Gitto, R., Buemi, M. R., Christ, F., Debyser, Z., & Ferro, S. (2016) · Molecular Informatics · doi:10.1002/minf.201501034 · Cited by 9
Self-citationGallay, K., Blot, G., Chahpazoff, M., Yajjou, H., Confort, M.-P., de Boisséson, C., Roux, A. L., Luengo, C., Fiorini, F., Lavigne, M., et al. (2019) · Virology · doi:10.1016/j.virol.2019.04.002 · Cited by 10
LinX: A Software Tool for Uncommon Cross-Linking Chemistry
Kukačka, Z., Rosůlek, M., Jelı́nek, J., Slavata, L., Kavan, D., & Novák, P. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00858 · Cited by 9
A perspective of the dynamic structure of the nucleus explored at the single-molecule level
Dange, T., Joseph, A., & Grünwald, D. (2010) · Chromosome Research · doi:10.1007/s10577-010-9156-5 · Cited by 7
“LEDGF/p75 also associates with IN and has also been implicated in participating in its nuclear import and/or the integration process (Cherepanov et al. 2003; Maertens et al. 2003).”
BackgroundGilroy, K. L., Terry, A., Naseer, A., de Ridder, J., Allahyar, A., Wang, W., Carpenter, E. J., Mason, A. L., Wong, G. K., Cameron, E. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154070 · Cited by 9
“For HIV, this process entails interaction between the viral integrase protein and LEDGF, a transcriptional co-activator that tethers the integration complex to chromatin and facilitates integration [8,9].”
BackgroundTan, T. C., Ng, C., & Leong, K. P. (2020) · Singapore Medical Journal · doi:10.11622/smedj.2020117 · Cited by 8
“DFS70/LEDGFp75 is also involved as a cofactor in HIV (human immunodeficiency virus) replication.((11)) The exact immunological role of DFS70 is not well understood; experts suggest that anti-DFS70 is an epiphenomenon of systemic inflammation.”
BackgroundLow Prevalence of Anti-DFS70 Antibodies in Children With ANA-Associated Autoimmune Disease
Freudenhammer, M., Salzer, U., Heselich, A., Hufnagel, M., & Janda, A. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.839928 · Cited by 8
“It was recognized to function as an oncoprotein in multiple types of solid cancers (6–10) and hematologic malignancies (11–13) and was shown to be involved in the integration of viral DNA into host chromatin in HIV infection (14, 15).”
BackgroundAjoge, H. O., Kohio, H. P., Paparisto, E., Coleman, M. D., Wong, K., Tom, S. K., Bain, K. L., Berry, C. C., Arts, E. J., & Barr, S. D. (2022) · Viruses · doi:10.3390/v14112494 · Cited by 10
Therapeutic Genes for Anti-HIV/AIDS Gene Therapy
Bovolenta, C., Porcellini, S., & Alberici, L. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/138920101405131111104009 · Cited by 8
Azzi, S., Parissi, V., Maroun, R. G., Eid, P., Mauffret, O., & Fermandjian, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0016001 · Cited by 8
“In addition to its strong avered immunological properties, the C-terminal portion extensively participates to the binding of LEDGF (lens epithelium derived gross factor) [27,57], a factor that is thought to tether the preintegration complex to chromatin and favor integration [65,66,67].”
BackgroundBaid, R., Scheinman, R. I., Shinohara, T., Singh, D. P., & Kompella, U. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024616 · Cited by 10
“LEDGF was also isolated in a screen for proteins that interact with the HIV integrase [16] and appears to be essential for nuclear targeting of the integrase in human cells [17].”
BackgroundHIV-1 Integrase Drug Discovery Comes of Age
Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 9
Self-citationGabizon, R., Faust, O., Benyamini, H., Nir, S., Loyter, A., & Friedler, A. (2012) · MedChemComm · doi:10.1039/c2md20225e · Cited by 8
The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
Prospective Strategies for Targeting HIV-1 Integrase Function
Luo, Y., & Muesing, M. A. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.205 · Cited by 9
“The peptide segment interacts specifically with the amino terminal and core domains of IN [43,45,48].”
BackgroundLevin, A., Hayouka, Z., Helfer, M., Brack‐Werner, R., Friedler, A., & Loyter, A. (2010) · Biopolymers · doi:10.1002/bip.21469 · Cited by 8
Inhibitors of human immunodeficiency virus type I integration
Hazuda, D. J. (2006) · Current Opinion in HIV and AIDS · doi:10.1097/01.coh.0000221594.57035.55 · Cited by 9
DFS70 Autoantibodies: Clinical Utility in Antinuclear Antibody Testing
Bossuyt, X. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad181 · Cited by 7
Dawei, Z., He, H.-Q., Mengmeng, L., Meng, Z., & Shunxing, G. (2016) · Scientific Reports · doi:10.1038/srep33477 · Cited by 8
Identification and Optimization of a Novel HIV-1 Integrase Inhibitor
Adu‐Ampratwum, D., Pan, Y., Koneru, P. C., Antwi, J., Hoyte, A. C., Kessl, J. J., Griffin, P. R., Kvaratskhelia, M., Fuchs, J. R., & Larue, R. C. (2022) · ACS Omega · doi:10.1021/acsomega.1c06378 · Cited by 8
Ubiquitination of non-lysine residues in the retroviral integrase
Wang, Z., Hou, X., Wang, Y., Xu, A., Cao, W., Liao, M., Zhang, R., & Tang, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.086 · Cited by 7
Chen, M., Li, W., Zhang, Z., Pan, J., Sun, Y., Zhang, X., Zhang, X., & Cui, Z. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02661 · Cited by 7
Musat, M., Nițulescu, G. M., Surleac, M. D., Tsatsakis, A. M., Spandidos, D. A., & Margina, D. M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10777 · Cited by 8
“…H171, W131, T174 and T125 which facilitate stronger interactions between the two dimers and also between dimer units, leading to in aggregation (61,62). notably, allini resistance mutations at residues 226, 235, 264 and 266 have highlighted the role cTd plays in protein assembly in the absence of…”
InfluentialHIV-1 integrase modulates the interaction of the HIV-1 cellular cofactor LEDGF/p75 with chromatin
Astiazaran, P., Bueno, M. T. D., Morales, E., Kugelman, J. R., Garcia-Rivera, J. A., & Llano, M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-27 · Cited by 15
“LEDGF/p75 persists tightly bound to chromatin during all the phases of the cell cycle [8-10].”
BackgroundXu, Z., Zheng, Y., Ao, Z., Clément, M., Mouland, A. J., Kalpana, G. V., Belhumeur, P., Cohen, É. A., & Yao, X. (2008) · Retrovirology · doi:10.1186/1742-4690-5-102 · Cited by 9
“Recent studies have shown that LEDGF/p75 directly interacts with HIV-1 IN [4] and this interaction is required for targeting of HIV-1 DNA to the chromosome [5-7].”
BackgroundOrtiz-Hernández, G. L., Sanchez-Hernández, E. S., Ochoa, P. T., & Casiano, C. A. (2024) · Cancers · doi:10.3390/cancers16233957 · Cited by 7
Kling, E., Spaller, T., Schiefner, J., Bönisch, D., & Winckler, T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky582 · Cited by 5
“Examples include the accumulation of HIV-1 integrations in protein-coding regions mediated by transcriptional coactivator lens epithelium-derived growth factor (LEDGF) (44,45), tethering of retrotransposon Ty5 to heterochromatin by Sir4 protein in S. cerevisiae (9), targeting of Schizosaccharomyces pombe Tf1 to Pol II…”
The histone methyltransferase SETD2 regulates HIV expression and latency
Bussey-Sutton, C. R., Ward, A., Fox, J. A., Turner, A. W., Peterson, J. J., Emery, A., Longoria, A. R., Gomez-Martinez, I., Jones, C. D., Hepperla, A. J., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012281 · Cited by 9
Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication
Li, M., Tucker, L. D., Asara, J. M., Cheruiyot, C. K., Lü, H., Wu, Z. J., Newstein, M., Dooner, M. S., Friedman, J. F., Lally, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82360 · Cited by 6
New designs for HIV-1 integrase inhibitors: a patent review (2018-present)
Taoda, Y., Sugiyama, S., & Seki, T. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2178300 · Cited by 7
“LEDGF/p75 binds to the same pocket which results in leading the preintegration complex (PIC) to transcriptionally active regions of chromatin [77].”
BackgroundLevin, A., Benyamini, H., Hayouka, Z., Friedler, A., & Loyter, A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07952.x · Cited by 6
Directed DNA Shuffling of Retrovirus and Retrotransposon Integrase Protein Domains
Qi, X., Vargas, E., Larsen, L. S. Z., Knapp, W., Hatfield, G. W., Lathrop, R. H., & Sandmeyer, S. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063957 · Cited by 7
“Despite the fact that LEDGF targeting appears to be specific for HIV-1, its interaction maps to the CCD with contributions from the NTD [17–20].”
BackgroundIntegration of human immunodeficiency virus as a target for antiretroviral therapy
Семенова, Е. А., Johnson, A. A., Marchand, C., & Pommier, Y. G. (2006) · Current Opinion in HIV and AIDS · doi:10.1097/01.coh.0000239850.14991.f9 · Cited by 8
Thys, W., Busschots, K., McNeely, M., Voet, A. R. D., Christ, F., & Debyser, Z. (2009) · HIV Therapy · doi:10.2217/17584310.3.2.171 · Cited by 6
Self-citationRetroviruses 2004: Review of the 2004 Cold Spring Harbor Retroviruses conference
Freed, E. O., & Ross, S. R. (2004) · Retrovirology · doi:10.1186/1742-4690-1-25 · Cited by 7
“One such host factor, lens epithelium-derived growth factor (LEDGF/p75), was recently reported to bind HIV-1 IN [37,38].”
BackgroundThe dynamics of interconverting D- and E-forms of the HIV-1 integrase N-terminal domain
Balasubramanian, S., Rajagopalan, M., & Ramaswamy, A. (2014) · European Biophysics Journal · doi:10.1007/s00249-014-0979-4 · Cited by 5
“Zn2+ coordination with HHCC maintains the structural fold of the NTD. H12N mutated IN fails to interact with LEDGF/ p75 due to the loss of Zn2+ coordination with the HHCC motif and evidences the importance of structural fold of NTD for LEGF/p75 interaction (Maertens et al. 2003).”
BackgroundAdachi, K., Manabe, T., Yamasaki, T., Suma, A., Orita, T., Furuzono, T., Adachi, T., Ohata, Y., Akiyama, Y., & Miyazaki, S. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129864 · Cited by 5
López-Sañudo, S., Alonso, I. F., & López‐Hoyos, M. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.03.009 · Cited by 5
High-avidity IgG Autoantibodies against DFS70/LEDGF in Atopic Dermatitis
Watanabe, K. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000170 · Cited by 5
“It was also identified as a growth factor that stimulates cell growth and activates the expression of heat shock and stress-related genes [2], and was shown to interact with HIV-1 integrase and to help target this protein to chromatin [3,4].”
BackgroundHIV-1 Integration into Chromatin: New Insights and Future Perspectives
Lesbats, P., Lavigne, M., & Parissi, V. (2011) · Future Virology · doi:10.2217/fvl.11.84 · Cited by 7
DFS70 antibodies – biomarkers for the exclusion of ANA-associated autoimmune rheumatic diseases
Conrad, K., Röber, N., Rudolph, S., & Mähler, M. (2015) · Journal of Laboratory Medicine · doi:10.1515/labmed-2015-0040 · Cited by 5
“Aside from a series of physiological functions, such as cell protection against stress-induced apoptosis, LEDGF/ p75 is a cofactor of HIV replication by interacting with the viral integrase [19].”
BackgroundSantos, S., Obukhov, Y., Nekhai, S. A., Pushkarsky, T., Břicháček, B., Bukrinsky, M., & Iordanskiy, S. (2016) · Virology · doi:10.1016/j.virol.2016.06.023 · Cited by 5
CTNNBL1 restricts HIV-1 replication by suppressing viral DNA integration into the cell genome
Liang, G., He, Y., Zhao, L., Ouyang, J., Geng, W., Zhang, X., Han, X., Jiang, Y., Ding, H., Xiong, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110533 · Cited by 5
COP9 signalosome subunit 6 binds and inhibits avian leukosis virus integrase
Wang, Z., Xu, A., Hou, X., Chen, F., Cao, W., Yu, J., Liao, M., & Tang, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.116 · Cited by 5
Changes in the accessibility of the HIV-1 Integrase C-terminus in the presence of cellular proteins
Benkhelifa‐Ziyyat, S., Bucher, S., Zanta, M.-A., Pasquet, J., & Danos, O. (2010) · Retrovirology · doi:10.1186/1742-4690-7-27 · Cited by 5
“IN activity is modulated by its interactions with viral and cellular proteins within the Pre-Integration Complex (PIC) [1,2]; these interactions protect it from degradation [4,5], target it to the relevant cell compartment [6,7] and enhance its catalytic activity [1,8,9].”
BackgroundKishimoto, N., & Misumi, S. (2024) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00605 · Cited by 5
Gu, W.-G., Liu, B., & Yuan, J. F. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.959020 · Cited by 4
“nuclear localization-defective mutant of LEDGF [56–59].”
Johns, B. A., Kawasuji, T., & Velthuisen, E. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737814-00149 · Cited by 6
George, A., & Raghavendra, N. K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.035 · Cited by 4
Zhang, Z., Yuan, S., Xu, S., Guo, D., Chen, L., Hou, W., & Wang, M. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00311-5 · Cited by 4
Baid, R., Upadhyay, A. K., Shinohara, T., & Kompella, U. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441618 · Cited by 7
“In vivo administration of C-terminal LEDGF325–530 potently inhibited HIV replication by competing with endogenous LEDGF for binding to HIV integrase (26).”
BackgroundInfluentialPassaes, C., Cardoso, C. C., Caetano, D. G., Teixeira, S. L. M., Guimarães, M. L., Campos, D. P., Veloso, V. G., Babič, D. Z., Stevenson, M., Moraes, M. O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101780 · Cited by 5
Validation of host factors of HIV integration as novel drug targets for anti-HIV therapy
Debyser, Z., Desimmie, B. A., Taltynov, O., Demeulemeester, J., & Christ, F. (2014) · MedChemComm · doi:10.1039/c3md00302g · Cited by 4
Self-citationProspects for Foamy Viral Vector Anti-HIV Gene Therapy
Nalla, A. K., & Trobridge, G. D. (2016) · Biomedicines · doi:10.3390/biomedicines4020008 · Cited by 6
“Lens epithelium derived growth factor (LEDGF) is a co-factor of HIV integrase that aids nuclear import of the viral pre-integration complex and supports chromosomal tethering of HIV [100–102].”
BackgroundCurrent status of targets and assays for anti-HIV drug screening
Tian, R., Liao, Q., & Chen, X. (2007) · Virologica Sinica · doi:10.1007/s12250-007-0049-5 · Cited by 4
“This interaction with LEDGF/p75 accounts for the karyophilic properties, chromosomal targeting of HIV-1 IN, protection of HIV-1 IN from the proteasome (41, 44).”
BackgroundCellular Cofactors of HIV Integration
Thys, W., Bartholomeeusen, K., Debyser, Z., & Rijck, J. D. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch9 · Cited by 4
Self-citationEvaluation of the activity of HIV-1 integrase over-expressed in eukaryotic cells
Maele, B. V., Eylen, L. V., Pluymers, W., & Debyser, Z. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.157 · Cited by 6
Self-citationThe role of chromatin in retroviral preintegration complex function
Sapp, N., Prakash, P., Chakraborty, R., Balasubramaniam, M., & Dash, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110440 · Cited by 3
“It has been demonstrated that LEDGF/p75 plays a direct role in HIV-1 integration and stimulates in vitro integration activity of lentiviral INs (82–84, 104, 116, 117).”
Metadata
- Authors
- Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., & Engelborghs, Y.
- Affiliations
- KU Leuven (BE)
- Rega Institute for Medical Research (BE)
- Corresponding author
- Debyser, Zeger
- Engelborghs, Yves
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 278
- Issue
- 35
- Pages
- 33528-33539
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2088335428
- Cited by
- 493
- References
- 68
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 6 · 2022: 13 · 2021: 9 · 2020: 13 · 2019: 13 · 2018: 13 · 2017: 14 · 2016: 24 · 2015: 22 · 2014: 40 · 2013: 23 · 2012: 37
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6267 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Vlaamse regering
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 integrase, LEDGF/p75, nuclear import, metaphase chromosomes, zinc-binding domain, protein-protein interaction, nucleolar localization
- MeSH terms
- Base Sequence, Cell Nucleus, Cells, Cultured, Cytoplasm, HeLa Cells, Humans, Microscopy, Fluorescence, Mitosis, Models, Genetic, Molecular Sequence Data, Mutation, Plasmids, Protein Binding, Recombinant Fusion Proteins, Transfection, Zinc, Blotting, Western, Alternative Splicing, Protein Structure, Tertiary, Microscopy, Confocal, Fluorescent Antibody Technique, Indirect, HIV Integrase, Active Transport, Cell Nucleus, RNA, Small Interfering, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.